UK News Archive

2019

July

Story / Jul 26, 2019

Transforming company culture to reimagine medicine: Novartis professor addresses NHS leaders at the Kings Fund

Read More
Media Release / Jul 17, 2019

Novartis’ Kisqali® (ribociclib) receives NICE recommendation for most common form of advanced breast cancer in combination with fulvestrant

Read More
Story / Jul 15, 2019

Applications are now open for the Greater Manchester Future of Health Challenge

Read More
Story / Jul 05, 2019

Partners in Patient Care: In-Reach Nurses

Read More

June

Media Release / Jun 04, 2019

Novartis Kisqali® (ribociclib) in combination with endocrine therapy significantly extends overall survival compared with endocrine therapy alone in pre-/perimenopausal women with HR+/HER2- advanced breast cancer in MONALEESA-7 trial

Read More

May

Story / May 30, 2019

Novartis UK proudly continues over 20 years of Community Partnership

Read More
Media Release / May 08, 2019

Novartis data at AAN show positive effect of siponimod on cognition in secondary progressive MS

Read More
Media Release / May 03, 2019

Novartis presents new migraine data demonstrating sustained efficacy of Aimovig®▼ (erenumab) to 52 weeks

Read More

April

Media Release / Apr 08, 2019

Novartis announces Aimovig® (erenumab) accepted for use by the Scottish Medicines Consortium for the prevention of chronic migraine

Read More

March

Wayra Health Hub Launch Networking
Story / Mar 15, 2019

Advancing healthcare through digital innovation – Novartis UK and Wayra UK launch The Health Hub

Read More

Related Links